Suchen
« Voherige |
21 - 30 von 37
|
Nächste »
Suchergebnisse
Select an image to start the slideshow
Identification of a bone morphogenetic protein type 2 receptor neutralizing antibody
1 of 10
Identification of Commercially-Available Antibodies that Block Ligand-Binding by BMPR2
2 of 10
Inhibition of BMP-Induced Osteoblast Differentiation
3 of 10
Loss of BMPR2 Expression in Skeletal Progenitor Cells Reduces Age-Related Bone Loss
4 of 10
Loss of BMPR2 Leads to High Bone Mass Due to Increased Osteoblast Activity
5 of 10
Loss of BMPR2 Leads to High Bone Mass Due to Increased Osteoblast Activity
6 of 10
Loss of the Nutrient Sensor Tas1R3 Leads to Reduced Bone Resorption
7 of 10
Muscle Regulatory Factors Regulate T1R3 Taste Receptor Expression
8 of 10
Muscle-derived factors influencing bone metabolism
9 of 10
N-linked Glycosylation of the Bone Morphogenetic Protein Receptor Type 2 (BMPR2) Enhances Ligand Binding
10 of 10